Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer

Abstract

Innate and adaptive immune responses in humans have evolved as protective mechanisms against infectious microorganisms. Toll-like receptors (TLRs) have an important role in the recognition of invading microorganisms. TLRs are the first receptors to detect potential pathogens and to initiate the immune response, and they form the crucial link between the innate and adaptive immune responses. TLRs also have an important role in the pathophysiology of infectious and inflammatory diseases. Increasing data suggest that the ability of certain individuals to respond properly to TLR ligands may be impaired by single-nucleotide polymorphisms (SNPs) within TLR genes, resulting in an altered susceptibility to infectious or inflammatory disease that might contribute to the pathogenesis of complex diseases such as cancer. The associations between diseases and SNPs are in the early stage of discovery. Important clinical insights are emerging, and these polymorphisms provide new understanding of common diseases. This review summarizes and discusses the studies that shed light on the relevance of these polymorphisms in human infectious and inflammatory diseases and cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Albiger B, Dahlberg S, Henriques-Normark B, Normark S . Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors. J Intern Med 2007; 261: 511–528.

    CAS  PubMed  Google Scholar 

  2. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF . A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998; 95: 588–593.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Du X, Poltorak A, Wei Y, Beutler B . Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 2000; 11: 362–371.

    CAS  PubMed  Google Scholar 

  4. Chuang T, Ulevitch RJ . Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 2001; 1518: 157–161.

    CAS  PubMed  Google Scholar 

  5. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303: 1522–1526.

    CAS  PubMed  Google Scholar 

  6. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274: 33419–33425.

    CAS  PubMed  Google Scholar 

  7. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA . Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001; 413: 732–738.

    CAS  PubMed  Google Scholar 

  8. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526–1529.

    CAS  PubMed  Google Scholar 

  9. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F . Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689–10692.

    CAS  PubMed  Google Scholar 

  10. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099–1103.

    Article  CAS  PubMed  Google Scholar 

  11. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740–745.

    CAS  PubMed  Google Scholar 

  12. Frantz S, Ertl G, Bauersachs J . Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007; 4: 444–454.

    CAS  PubMed  Google Scholar 

  13. Kim JK . Fat uses a TOLL—road to connect inflammation and diabetes. Cell Metab 2006; 4: 417–419.

    CAS  PubMed  Google Scholar 

  14. Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM . Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 2007; 7: 1271–1285.

    CAS  PubMed  Google Scholar 

  15. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R . Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229–241.

    CAS  PubMed  Google Scholar 

  16. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749–3752.

    CAS  PubMed  Google Scholar 

  17. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085–2088.

    CAS  PubMed  Google Scholar 

  18. Takeda K, Takeuchi O, Akira S . Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res 2002; 8: 459–463.

    CAS  PubMed  Google Scholar 

  19. Sun J, Wiklund F, Hsu FC, Bälter K, Zheng SL, Johansson JE et al. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 480–485.

    CAS  PubMed  Google Scholar 

  20. Hawn TR, Misch EA, Dunstan SJ, Thwaites GE, Lan NT, Quy HT et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 2007; 37: 2280–2289.

    CAS  PubMed  Google Scholar 

  21. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E et al. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 2007; 178: 7520–7524.

    Article  CAS  PubMed  Google Scholar 

  22. Yang CA, Scheibenbogen C, Bauer S, Kleinle C, Wex T, Bornschein J et al. A frequent Toll-like receptor 1 gene polymorphism affects NK- and T-cell INF-γ production and is associated with Helicobacter pylori-induced gastric disease. Helicobacter 2013; 18: 13–21.

    PubMed  Google Scholar 

  23. Omueti KO, Mazur DJ, Thompson KS, Lyle EA, Tapping RI . The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J Immunol 2007; 178: 6387–6394.

    CAS  PubMed  Google Scholar 

  24. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA . A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68: 6398–6401.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Schröder NW, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol 2005; 175: 2534–2540.

    PubMed  Google Scholar 

  26. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004; 23: 219–223.

    CAS  PubMed  Google Scholar 

  27. Tabel Y, Berdeli A, Mir S . Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children. Int J Immunogenet 2007; 34: 399–405.

    CAS  PubMed  Google Scholar 

  28. Kutukculer N, Yeniay BS, Aksu G, Berdeli A . Arg753Gln polymorphism of the human toll-like receptor-2 gene in children with recurrent febrile infections. Biochem Genet 2007; 45: 507–514.

    CAS  PubMed  Google Scholar 

  29. Berdeli A, Celik HA, Ozyürek R, Dogrusoz B, Aydin HH . TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J Mol Med 2005; 83: 535–541.

    CAS  PubMed  Google Scholar 

  30. Ozen S, Berdeli A, Turel B, Kutlay S, Yalcinkaya F, Arici M et al. Arg753Gln TLR-2 polymorphism in familial mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease. J Rheumatol 2006; 33: 2498–2500.

    CAS  PubMed  Google Scholar 

  31. Hamann L, Gomma A, Schröder NW, Stamme C, Glaeser C, Schulz S et al. A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. J Mol Med 2005; 83: 478–485.

    CAS  PubMed  Google Scholar 

  32. Park Y, Park S, Yoo E, Kim D, Shin H . Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility. Ann NY Acad Sci 2004; 1037: 170–174.

    CAS  PubMed  Google Scholar 

  33. Eid AJ, Brown RA, Paya CV, Razonable RR . Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation 2007; 84: 511–516.

    CAS  PubMed  Google Scholar 

  34. Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR . Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis 2007; 44: 1315–1320.

    CAS  PubMed  Google Scholar 

  35. Krediet TG, Wiertsema SP, Vossers MJ, Hoeks SB, Fleer A, Ruven HJ et al. Toll-like receptor 2 polymorphism is associated with preterm birth. Pediatr Res 2007; 62: 474–476.

    CAS  PubMed  Google Scholar 

  36. Kang TJ, Chae GT . Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 2001; 31: 53–58.

    CAS  PubMed  Google Scholar 

  37. Kang TJ, Lee SB, Chae GT . A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 2002; 20: 56–62.

    CAS  PubMed  Google Scholar 

  38. Kang TJ, Yeum CE, Kim BC, You EY, Chae GT . Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation. Immunology 2004; 112: 674–680.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Ben Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K . Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 2004; 11: 625–626.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Schröder NW, Hermann C, Hamann L, Göbel UB, Hartung T, Schumann RR . High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med 2003; 81: 368–372.

    PubMed  Google Scholar 

  41. Hise AG, Hazlett FE, Bockarie MJ, Zimmerman PA, Tisch DJ, Kazura JW . Polymorphisms of innate immunity genes and susceptibility to lymphatic filariasis. Genes Immun 2003; 4: 524–527.

    CAS  PubMed  Google Scholar 

  42. Berdeli A, Emingil G, Han Saygan B, Gurkan A, Atilla G, Köse T et al. TLR2 Arg753Gly, TLR4 Asp299Gly and Thr399Ile gene polymorphisms are not associated with chronic periodontitis in a Turkish population. J Clin Periodontol 2007; 34: 551–557.

    CAS  PubMed  Google Scholar 

  43. Düzgün N, Duman T, Haydardedeoğlu FE, Tutkak H . The lack of genetic association of the Toll-like receptor 2 (TLR2) Arg753Gln and Arg677Trp polymorphisms with rheumatic heart disease. Clin Rheumatol 2007; 26: 915–919.

    PubMed  Google Scholar 

  44. Yoon HJ, Choi JY, Kim CO, Park YS, Kim MS, Kim YK et al. Lack of Toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia. J Korean Med Sci 2006; 21: 979–982.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Sánchez E, Orozco G, López-Nevot MA, Jiménez-Alonso J, Martin J . Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004; 63: 54–57.

    PubMed  Google Scholar 

  46. von Aulock S, Schröder NW, Traub S, Gueinzius K, Lorenz E, Hartung T et al. Heterozygous toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory responses. Infect Immun 2004; 72: 1828–1831.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Merx S, Neumaier M, Wagner H, Kirschning CJ, Ahmad-Nejad P . Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene. Hum Mol Genet 2007; 10: 1225–1232.

    Google Scholar 

  48. Thuong NT, Hawn TR, Thwaites GE, Chau TT, Lan NT, Quy HT et al. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun 2007; 8: 422–428.

    CAS  PubMed  Google Scholar 

  49. Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, Braun-Fahrländer C et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004; 113: 482–488.

    CAS  PubMed  Google Scholar 

  50. Junjie X, Songyao J, Minmin S, Yanyan S, Baiyong S, Xiaxing D et al. The association between Toll-like receptor 2 single-nucleotide polymorphism and hepatocellular carcinoma susceptibility. BMC Cancer 2012; 12: 57.

    PubMed  PubMed Central  Google Scholar 

  51. Theodoropoulos GE, Saridakis V, Karantanos T, Michalopoulos NV, Zagouri F, Kontogianni P et al. Toll-like receptor gene polymorphisms may confer increased susceptibility to breast cancer development. Breast 2012; 21: 534–538.

    PubMed  Google Scholar 

  52. Zeng HM, Pan KF, Zhang Y, Zhang L, Ma JL, Zhou T et al. Genetic variants of Toll-like receptors 2 and 5, Helicobacter pylori infection, and risk of gastric cancer and its precursors in a Chinese population. Cancer Epidemiol Biomarkers Prev 2011; 20: 2594–2602.

    CAS  PubMed  Google Scholar 

  53. Ranjith-Kumar CT, Miller W, Sun J, Xiong J, Santos J, Yarbrough I et al. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J Biol Chem 2007; 282: 17696–17705.

    CAS  PubMed  Google Scholar 

  54. Ueta M, Sotozono C, Inatomi T, Kojima K, Tashiro K, Hamuro J et al. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens–Johnson syndrome. Br J Ophthalmol 2007; 91: 962–965.

    PubMed  PubMed Central  Google Scholar 

  55. Pirie FJ, Pegoraro R, Motala AA, Rauff S, Rom L, Govender T et al. Toll-like receptor 3 gene polymorphisms in South African blacks with type 1 diabetes. Tissue Antigens 2005; 66: 125–130.

    CAS  PubMed  Google Scholar 

  56. Castro FA, Försti A, Buch S, Kalthoff H, Krauss C, Bauer M et al. TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer. Eur J Cancer 2011; 47: 1203–1210.

    CAS  PubMed  Google Scholar 

  57. Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Lal P et al. Evaluation of Toll-like receptor 3 (c.1377C/T) and 9 (G2848A) gene polymorphism in cervical cancer susceptibility. Mol Biol Rep 2011; 38: 4715–4721.

    CAS  PubMed  Google Scholar 

  58. Smirnova I, Poltorak A, Chan EK, McBride C, Beutler B . Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol 2000; 1 research002.1-research002.10.

    Google Scholar 

  59. Smirnova I, Hamblin MT, McBride C, Beutler B, Di Rienzo A . Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics 2001; 158: 1657–1664.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187–191.

    CAS  PubMed  Google Scholar 

  61. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E et al. Toll-like receptor 4 polymorphisms and atherogenesis. New Engl J Med 2002; 18: 185–192.

    Google Scholar 

  62. Fagerås Böttcher M, Hmani-Aifa M, Lindström A, Jenmalm MC, Mai XM, Nilsson L et al. A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J Allergy Clin Immunol 2004; 114: 561–567.

    PubMed  Google Scholar 

  63. Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW . TLR4 and TNF-α polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 2004; 41: 808–813.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Lorenz E, Mira JP, Frees KL, Schwartz DA . Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med 2002; 162: 1028–1032.

    CAS  PubMed  Google Scholar 

  65. Lorenz E, Hallman M, Marttila R, Haataja R, Schwartz DA . Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 2002; 52: 373–376.

    CAS  PubMed  Google Scholar 

  66. Browning BL, Huebner C, Petermann I, Gearry RB, Barclay ML, Shelling AN et al. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol 2007; 102: 2504–2512.

    CAS  PubMed  Google Scholar 

  67. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T et al. Deficient host–bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis. Gut 2004; 53: 987–992.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Lakatos PL, Lakatos L, Szalay F, Willheim-Polli C, Osterreicher C, Tulassay Z et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn’s disease: phenotype–genotype correlations. World J Gastroenterol 2005; 11: 1489–1495.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Montes AH, Asensi V, Alvarez V, Valle E, Ocaña MG, Meana A et al. The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis. Clin Exp Immunol 2006; 143: 404–413.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Karoly E, Fekete A, Banki NF, Szebeni B, Vannay A, Szabo AJ et al. Heat shock protein 72 (HSPA1B) gene polymorphism and Toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children. Pediatr Res 2007; 61: 371–374.

    CAS  PubMed  Google Scholar 

  71. Tulic MK, Hurrelbrink RJ, Prêle CM, Laing IA, Upham JW, Le Souef P et al. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol 2007; 179: 132–140.

    CAS  PubMed  Google Scholar 

  72. Hellmig S, Fischbach W, Goebeler-Kolve ME, Fölsch UR, Hampe J, Schreiber S . Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma 2005; 46: 869–872.

    CAS  PubMed  Google Scholar 

  73. Hofner P, Gyulai Z, Kiss ZF, Tiszai A, Tiszlavicz L, Tóth G et al. Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter 2007; 12: 124–131.

    CAS  PubMed  Google Scholar 

  74. Kato I, Canzian F, Plummer M, Franceschi S, van Doorn LJ, Vivas J et al. Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig Dis Sci 2007; 52: 254–261.

    CAS  PubMed  Google Scholar 

  75. Trejo-de la OA, Torres J, Pérez-Rodríguez M, Camorlinga-Ponce M, Luna LF, Abdo-Francis JM et al. TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori-associated gastroduodenal diseases. Clin Immunol 2008; 129: 333–340.

    Google Scholar 

  76. Pabst S, Baumgarten G, Stremmel A, Lennarz M, Knüfermann P, Gillissen A et al. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol 2006; 143: 420–426.

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Rudofsky Jr G, Reismann P, Witte S, Humpert PM, Isermann B, Chavakis T et al. Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes. Diabetes Care 2004; 27: 179–183.

    CAS  PubMed  Google Scholar 

  78. Palmer SM, Burch LH, Mir S, Smith SR, Kuo PC, Herczyk WF et al. Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 2006; 20: 30–36.

    PubMed  Google Scholar 

  79. Minoretti P, Gazzaruso C, Vito CD, Emanuele E, Bianchi M, Coen E et al. Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer’s disease. Neurosci Lett 2006; 391: 147–149.

    CAS  PubMed  Google Scholar 

  80. Van der Graaf CA, Netea MG, Morré SA, Den Heijer M, Verweij PE, Van der Meer JW et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 2006; 17: 29–34.

    CAS  PubMed  Google Scholar 

  81. Hofner P, Balog A, Gyulai Z, Farkas G, Rakonczay Z, Takács T et al. Polymorphism in the IL-8 gene, but not in the TLR4 gene, increases the severity of acute pancreatitis. Pancreatology 2006; 6: 542–548.

    CAS  PubMed  Google Scholar 

  82. Szebeni B, Szekeres R, Rusai K, Vannay A, Veres G, Treszl A et al. Genetic polymorphisms of CD14, toll-like receptor 4, and caspase-recruitment domain 15 are not associated with necrotizing enterocolitis in very low birth weight infants. J Pediatr Gastroenterol Nutr 2006; 42: 27–31.

    CAS  PubMed  Google Scholar 

  83. Na KS, Kim TH, Rahman P, Peddle L, Choi CB, Inman RD . Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean population. Rheumatol Int 2008; 28: 627–630.

    CAS  PubMed  Google Scholar 

  84. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ . Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 2005; 65: 11771–11778.

    CAS  PubMed  Google Scholar 

  85. Duan ZX, Zhu PF, Dong H, Gu W, Yang C, Liu Q et al. Functional significance of the TLR4/11367 polymorphism identified in Chinese Han population. Shock 2007; 28: 160–164.

    CAS  PubMed  Google Scholar 

  86. Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L . Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res 2008; 68: 4026–4030.

    CAS  PubMed  Google Scholar 

  87. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires’ disease. J Exp Med 2003; 198: 1563–1572.

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Dunstan SJ, Hawn TR, Hue NT, Parry CP, Ho VA, Vinh H et al. Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J Infect Dis 2005; 191: 1068–1071.

    CAS  PubMed  Google Scholar 

  89. Demirci FY, Manzi S, Ramsey-Goldman R, Kenney M, Shaw PS, Dunlop-Thomas CM et al. Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. J Rheumatol 2007; 34: 1708–1711.

    CAS  PubMed  Google Scholar 

  90. Hawn TR, Wu H, Grossman JM, Hahn BH, Tsao BP, Aderem A . A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc Natl Acad Sci USA 2005; 102: 10593–10597.

    CAS  PubMed  PubMed Central  Google Scholar 

  91. Gewirtz AT, Vijay-Kumar M, Brant SR, Duerr RH, Nicolae DL, Cho JH . Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn’s disease. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1157–G1163.

    CAS  PubMed  Google Scholar 

  92. Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L et al. Sequence variants in Toll-like receptor gene cluster (TLR6–TLR1–TLR10) and prostate cancer risk. J Natl Cancer Inst 2005; 97: 525–532.

    CAS  PubMed  Google Scholar 

  93. Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlietinck R, Rutgeerts P et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 2006; 12: 1–8.

    PubMed  Google Scholar 

  94. Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, Call TG et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007; 110: 4455–4463.

    CAS  PubMed  PubMed Central  Google Scholar 

  95. Cheng PL, Eng HL, Chou MH, You HL, Lin TM . Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Transl Res 2007; 150: 311–318.

    CAS  PubMed  Google Scholar 

  96. Schott E, Witt H, Neumann K, Taube S, Oh DY, Schreier E et al. A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. J Hepatol 2007; 47: 203–211.

    CAS  PubMed  Google Scholar 

  97. Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case–control disease association studies. Genomics 2003; 81: 85–91.

    CAS  PubMed  Google Scholar 

  98. Török HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C . Crohn’s disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 2004; 127: 365–366.

    PubMed  Google Scholar 

  99. Lammers KM, Ouburg S, Morré SA, Crusius JB, Gionchett P, Rizzello F et al. Combined carriership of TLR9−1237C and CD14−260T alleles enhances the risk of developing chronic relapsing pouchitis. World J Gastroenterol 2005; 11: 7323–7329.

    CAS  PubMed  PubMed Central  Google Scholar 

  100. Ng MW, Lau CS, Chan TM, Wong WH, Lau YL . Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic lupus erythematosus in Chinese. Rheumatology (Oxford) 2005; 44: 1456–1457.

    CAS  Google Scholar 

  101. De Jager PL, Richardson A, Vyse TJ, Rioux JD . Genetic variation in toll-like receptor 9 and susceptibility to systemic lupus erythematosus. Arthritis Rheum 2006; 54: 1279–1282.

    CAS  PubMed  Google Scholar 

  102. Berghöfer B, Frommer T, König IR, Ziegler A, Chakraborty T, Bein G et al. Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance. Clin Exp Allergy 2005; 35: 1147–1154.

    PubMed  Google Scholar 

  103. Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki M et al. An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 2004; 34: 177–183.

    CAS  PubMed  Google Scholar 

  104. Kikuchi K, Lian ZX, Kimura Y, Selmi C, Yang GX, Gordon SC et al. Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J Autoimmun 2005; 24: 347–352.

    CAS  PubMed  Google Scholar 

  105. Mockenhaupt FP, Hamann L, von Gaertner C, Bedu-Addo G, von Kleinsorgen C, Schumann RR et al. Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J Infect Dis 2006; 194: 184–188.

    CAS  PubMed  Google Scholar 

  106. Bochud PY, Hersberger M, Taffé P, Bochud M, Stein CM, Rodrigues SD et al. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 2007; 21: 441–446.

    CAS  PubMed  Google Scholar 

  107. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J et al. Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk. BMC Cancer 2010; 10: 382.

    PubMed  PubMed Central  Google Scholar 

  108. Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 2005; 174: 2942–2950.

    CAS  PubMed  Google Scholar 

  109. Akira S, Takeda K . Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499–511.

    CAS  PubMed  Google Scholar 

  110. Lazarus R, Raby BA, Lange C, Silverman EK, Kwiatkowski DJ, Vercelli D et al. Toll-like receptor 10 genetic variation is associated with asthma in two independent samples. Am J Respir Crit Care Med 2004; 170: 594–600.

    PubMed  Google Scholar 

  111. Kormann MS, Depner M, Hartl D, Klopp N, Illig T, Adamski J et al. Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol 2008; 122: 86–92.

    CAS  PubMed  Google Scholar 

  112. Abad C, González-Escribano MF, Diaz-Gallo LM, Lucena-Soto JM, Márquez JL, Leo E et al. Association of Toll-like receptor 10 and susceptibility to Crohn’s disease independent of NOD2. Genes Immun 2011; 12: 635–642.

    CAS  PubMed  Google Scholar 

  113. Morgan AR, Lam WJ, Han DY, Fraser AG, Ferguson LR . Genetic variation within TLR10 is associated with Crohn’s disease in a New Zealand population. Hum Immunol 2012; 73: 416–420.

    CAS  PubMed  Google Scholar 

  114. Kim SK, Park HJ, Hong IK, Chung JH, Eun YG . A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population. Endocrine 2013; 43: 161–169.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by Hospital Infantil de México Federico Gómez, Grant No. HIM/022/2011 SSA 944.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Maldonado-Bernal.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trejo-de la O, A., Hernández-Sancén, P. & Maldonado-Bernal, C. Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer. Genes Immun 15, 199–209 (2014). https://doi.org/10.1038/gene.2014.10

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gene.2014.10

This article is cited by

Search

Quick links